> Yes there is some oral bioavailability, but for non-stomach the standard BPC-157 is not optimal. Please post proof from a study. Some studies used the oral r

> Yes there is some oral bioavailability, but for non-stomach the standard BPC-157 is not optimal. Please post proof from a study. Some studies used the oral route in animals if I recall. > SubQ injections closest to the site of injury are preferred. According to who? > The bodybuilders are helping us explore these molecules and many times doing it in an open source, collaborative way. They will have blood work done and post it before and after the run. The community evaluates their bloodwork and can validate whether it worked, if the source was good etc. It's pretty impressive real-time, science experiments. And if you hang around and read all the science and see enough of those n=1 studies, the patterns and consensus that emerge are pretty clear. We have no way of knowing who these people are, what they are taking, or if they are underground labs posting to drum up business. The companies developing SARMs want to test them on people that have cancer cachexia. So yes, researching with bodybuilders is completely useless.